Kalaris Therapeutics News and Activities

Kalaris Therapeutics is a company listed under the stock ticker KLRS (US).

Acquisition, funding and merger involving Kalaris Therapeutics.

• AlloVir and Kalaris Therapeutics have announced they will merge  (posted on March 24 2025)..

View the org chart displaying its 21 main executives

Most searched biographies at Kalaris Therapeutics

• Andrew Oxtoby, President and Chief Executive Officer
• Napoleone Ferrara, Director
• Morana Jovan-Embiricos, Director (until Aug 1 2026)

Popular executive movements at Kalaris Therapeutics

• Liisa Bayko has joined the company as Chief Financial Officer  (posted on July 20 2026).
• Laurie Keating will join the company as Director on Aug. 1, 2026  (posted on July 7 2026).
• Morana Jovan-Embiricos, Director, will leave the company on Aug. 1, 2026  (posted on July 7 2026).

Click here to view some more movements at Kalaris Therapeutics

Create your alert
to follow the executive moves at Kalaris Therapeutics.

Kalaris Therapeutics has 2,430 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Tempus has announced the acquisition of Personalis  (posted on July 20 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Kalaris Therapeutics

• Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD | Wed, 12/17/2025 - 16:01
• Kalaris Therapeutics – Your vision, our mission
• Kalaris and AlloVir Announce Stockholder Approval of Merger
• AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina

Social media about Kalaris Therapeutics

• Kalaris Therapeutics on Wikipedia, Google News & Yahoo Finance
• Kalaris Therapeutics on LinkedIn, X (Twitter) & YouTube